Combining the results of this study, it can be concluded that the regulation of the PI3K/AKT and EGFR-MAPK signaling pathways by the three anti-NSCLC compounds in IPTF is one of the mechanisms underlying the anti-NSCLC activity of IPTF. Here, AKT1 is linked to non-small cell lung carcinoma.